Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term aripiprazole in children and adolescents with autistic disorder
jRCT2080221819Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Aripiprazole with Placebo (2 arms).
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on jRCT2080221819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221819.